BioWorld-Insight-2003-06-02
Stock Winners and Losers For The Week
Remicade Gaining Favor As IBD Therapy; Other Targets Explored
When writer Jonathan Ames remarked in print that he suffered from "infuriated bowel syndrome," the remark might have been amusing but also was full of painful meaning - especially for the legions afflicted with the condition under its more common name: inflammatory bowel disease (IBD), consisting mainly of ulcerative colitis and Crohn's disease.

